Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
16:43:58 EDT Sun 28 Apr 2024
Enter Symbol
or Name
USA
CA



News for U:NYMX from 2023-04-27 to 2024-04-26 - 34 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-03-27 13:30U:NYMXNews ReleaseNymox Pharmaceutical wins case against ex-employees
2023-12-27 14:11U:NYMXNews ReleaseNymox working on response on 1st Nymozarfex submission
2023-11-30 16:43U:NYMXNews ReleaseNymox injunction against Lanham et al. granted
2023-11-21 15:21U:NYMXNews ReleaseNymox lawsuit against AscellaHealth accepted by court
2023-11-15 15:38U:NYMXSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-15 15:28U:NYMXSEDAR Interim MD & ASEDAR Interim MD & A
2023-11-09 14:32U:NYMXNews ReleaseNymox sues Ascella for $250M over corporate espionage
2023-11-03 15:13U:NYMXNews ReleaseNymox wins ex parte order suspension vs Lanham et. al
2023-11-03 14:39U:NYMXNews ReleaseNymox receives restraining order against ex-employees
2023-10-27 16:57U:NYMXNews ReleaseNymox urges holders not to attend "improper" meeting
2023-10-26 10:56U:NYMXNews ReleaseNymox's Nymozarfex MAA accepted for review in U.K.
2023-09-25 11:44U:NYMXNews ReleaseNymox submits MAA for Nymozarfex in U.K.
2023-08-29 14:35U:NYMXNews ReleaseNymox completes $2-million (U.S.) private placement
2023-08-14 16:48U:NYMXSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-02 13:20U:NYMXNews ReleaseNymox to receive $2M (U.S.) investment from Robinson
2023-07-31 12:43U:NYMXNews ReleaseNymox accuses ex-CFO Riley of slipping one past board
2023-07-25 11:19U:NYMXNews ReleaseNymox releases Nymozarfex clinical trial results
2023-07-25 10:33U:NYMXNews ReleaseNymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results
2023-07-18 13:43U:NYMXNews ReleaseNymox receives U.S. patents for Nymozarfex
2023-07-18 10:46U:NYMXNews ReleaseNymox Reports on U.S. Patent Issuances
2023-07-13 12:51U:NYMXNews ReleaseNymox details reasons for rejecting transaction
2023-07-13 10:17U:NYMXNews ReleaseNymox Update
2023-07-12 10:07U:NYMXNews ReleaseNymox Pharmaceutical appoints Doody VP, director
2023-07-12 09:30U:NYMXNews ReleaseNymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of Nymox
2023-07-07 17:03U:NYMXNews ReleaseNYMOX Update
2023-07-07 12:51U:NYMXNews ReleaseNymox not to proceed with proposed transaction
2023-07-05 18:12U:NYMXNews ReleaseNymox Delisting from NASDAQ
2023-07-05 09:44U:NYMXNews ReleaseNymox to delist from Nasdaq, move to OTC market July 7
2023-05-12 22:58U:NYMXSEDAR MD & ASEDAR MD & A
2023-05-12 22:53U:NYMXSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-05-10 10:00U:NYMXNews ReleaseNymox Provides Current Update
2023-05-02 18:34U:NYMXSEDAR MD & ASEDAR MD & A
2023-05-02 18:31U:NYMXSEDAR Annual ReportSEDAR Annual Report
2023-05-02 18:21U:NYMXSEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements